Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B S Coller

Showing results (131-140 of 163) with videos related to

Pageof 17
Sort By:
Circulation|September 4, 1998
Activation of platelets in platelet-rich plasma by rotablation is speed-dependent and can be inhibited by abciximab (c7E3 Fab; ReoPro)M S Williams, B S Coller, H J Väänänen, et al.
Blood|September 1, 1985
Related binding mechanisms for fibrinogen, fibronectin, von Willebrand factor, and thrombospondin on thrombin-stimulated human plateletsE F Plow, R P McEver, B S Coller, et al.
Blood|August 1, 1996
Analysis of GPIIb/IIIa receptor number by quantification of 7E3 binding to human plateletsC L Wagner, M A Mascelli, D S Neblock, et al.
Blood|June 1, 1997
7E3 F(ab')2, a monoclonal antibody to the platelet GPIIb/IIIa receptor, protects against microangiopathic hemolytic anemia and microvascular thrombotic renal failure in baboons treated with C4b binding protein and a sublethal infusion of Escherichia coliF B Taylor, B S Coller, A C Chang, et al.
The Journal of Clinical Investigation|April 1, 1993
The thrombin receptor extracellular domain contains sites crucial for peptide ligand-induced activationW F Bahou, B S Coller, C L Potter, et al.
Journal of Thrombosis and Haemostasis : JTH|August 2, 2006
Diversity of Glanzmann thrombasthenia in southern India: 10 novel mutations identified among 15 unrelated patientsE J R Nelson, S C Nair, H Peretz, et al.
Arteriosclerosis (Dallas, Tex.)|September 1, 1987
Deficiency of plasma protein S, protein C, or antithrombin III and arterial thrombosisB S Coller, J Owen, J Jesty, et al.
Blood|September 1, 1981
Normal pregnancy in a patient with a prior postpartum factor VIII inhibitor: with observations on pathogenesis and prognosisB S Coller, M B Hultin, L W Hoyer, et al.
The Journal of Clinical Investigation|January 1, 1994
Glanzmann thrombasthenia secondary to a Gly273-->Asp mutation adjacent to the first calcium-binding domain of platelet glycoprotein IIbM Poncz, S Rifat, B S Coller, et al.
Chest|October 1, 1995
Antithrombotic therapy in patients undergoing coronary angioplastyJ J Popma, B S Coller, E M Ohman, et al.
Pageof 17

Showing results (131-140 of 163) with videos related to

Sort By:
Pageof 17
Circulation|September 4, 1998
Activation of platelets in platelet-rich plasma by rotablation is speed-dependent and can be inhibited by abciximab (c7E3 Fab; ReoPro)M S Williams, B S Coller, H J Väänänen, et al.
Blood|September 1, 1985
Related binding mechanisms for fibrinogen, fibronectin, von Willebrand factor, and thrombospondin on thrombin-stimulated human plateletsE F Plow, R P McEver, B S Coller, et al.
Blood|August 1, 1996
Analysis of GPIIb/IIIa receptor number by quantification of 7E3 binding to human plateletsC L Wagner, M A Mascelli, D S Neblock, et al.
Blood|June 1, 1997
7E3 F(ab')2, a monoclonal antibody to the platelet GPIIb/IIIa receptor, protects against microangiopathic hemolytic anemia and microvascular thrombotic renal failure in baboons treated with C4b binding protein and a sublethal infusion of Escherichia coliF B Taylor, B S Coller, A C Chang, et al.
The Journal of Clinical Investigation|April 1, 1993
The thrombin receptor extracellular domain contains sites crucial for peptide ligand-induced activationW F Bahou, B S Coller, C L Potter, et al.
Journal of Thrombosis and Haemostasis : JTH|August 2, 2006
Diversity of Glanzmann thrombasthenia in southern India: 10 novel mutations identified among 15 unrelated patientsE J R Nelson, S C Nair, H Peretz, et al.
Arteriosclerosis (Dallas, Tex.)|September 1, 1987
Deficiency of plasma protein S, protein C, or antithrombin III and arterial thrombosisB S Coller, J Owen, J Jesty, et al.
Blood|September 1, 1981
Normal pregnancy in a patient with a prior postpartum factor VIII inhibitor: with observations on pathogenesis and prognosisB S Coller, M B Hultin, L W Hoyer, et al.
The Journal of Clinical Investigation|January 1, 1994
Glanzmann thrombasthenia secondary to a Gly273-->Asp mutation adjacent to the first calcium-binding domain of platelet glycoprotein IIbM Poncz, S Rifat, B S Coller, et al.
Chest|October 1, 1995
Antithrombotic therapy in patients undergoing coronary angioplastyJ J Popma, B S Coller, E M Ohman, et al.
Pageof 17